Gheuens Sarah

Track

Insider profile

Gheuens Sarah's trades of Agios Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-06 2026-08-04
PlS Planned sale
92,910 +21.3%
429.77
US$4,656,252 		92,910 +21.3% 429.77 US$4,656,252
2026-08-04 2026-08-04
PrS Proposed sale
40,005
244.45
US$359,720 		40,005 244.45 US$359,720
2026-07-02 2026-07-01
PlS Planned sale
5,112 +44.7%
486.62
US$3,076,625 		5,112 +44.7% 486.62 US$3,076,625
2026-07-01 2026-07-01
PrS Proposed sale
4,007
37.56
US$150,503 		4,007 37.56 US$150,503
2026-04-06 2026-04-02
PlS Planned sale
2,940 -3.5%
34.71
US$102,047 		2,940 -3.5% 34.71 US$102,047
2026-04-02 2026-04-02
PrS Proposed sale
2,940
34.19
US$100,519 		2,940 34.19 US$100,519
2026-03-03 2026-03-02
PlS Planned sale
1,187 -1.6%
28.96
US$34,376 		1,187 -1.6% 28.96 US$34,376
2026-03-03 2026-03-02
PlS Planned sale
1,681 -2.3%
28.96
US$48,682 		1,681 -2.3% 28.96 US$48,682
2026-03-03 2026-03-02
PlS Planned sale
1,187 -1.7%
28.96
US$34,376 		1,187 -1.7% 28.96 US$34,376
2026-03-02 2026-03-02
PrS Proposed sale
4,055
30.23
US$122,583 		4,055 30.23 US$122,583
2026-01-02 2025-12-30
PlS Planned sale
2,932 -4.3%
27.09
US$79,428 		2,932 -4.3% 27.09 US$79,428
2025-12-30 2025-12-30
PrS Proposed sale
2,932
27.16
US$79,633 		2,932 27.16 US$79,633
2025-11-13 2025-11-11
PlS Planned sale
2,454 -3.8%
43.78
US$107,436 		2,454 -3.8% 43.78 US$107,436
2025-11-12 2025-11-11
PrS Proposed sale
2,454
43.78
US$107,441 		2,454 43.78 US$107,441
2025-11-03 2025-10-30
PlS Planned sale
200 -0.3%
43.81
US$8,762 		200 -0.3% 43.81 US$8,762
2025-10-30 2025-10-30
PrS Proposed sale
200
43.81
US$8,762 		200 43.81 US$8,762
2025-10-29 2025-10-27
PlS Planned sale
3,302 -5.1%
43.92
US$145,024 		3,302 -5.1% 43.92 US$145,024
2025-10-27 2025-10-27
PrS Proposed sale
3,302
43.92
US$145,028 		3,302 43.92 US$145,028
2025-07-11 2025-07-09
PlS Planned sale
847 -1.4%
38.76
US$32,830 		847 -1.4% 38.76 US$32,830
2025-07-11 2025-07-09
PlS Planned sale
11,067 -15.1%
37.93
US$419,771 		11,067 -15.1% 37.93 US$419,771
2025-07-09 2025-07-09
PrS Proposed sale
11,914
37.99
US$452,632 		11,914 37.99 US$452,632
2025-07-03 2025-07-01
PlS Planned sale
4,091 -6.3%
34.17
US$139,789 		4,091 -6.3% 34.17 US$139,789
2025-07-01 2025-07-01
PrS Proposed sale
4,091
34.37
US$140,608 		4,091 34.37 US$140,608
2025-06-26 2025-06-24
PlS Planned sale
2,909 -4.9%
33.54
US$97,568 		2,909 -4.9% 33.54 US$97,568
2025-06-24 2025-06-24
PrS Proposed sale
1,761
34.41
US$60,596 		1,761 34.41 US$60,596
2025-03-04 2025-03-03
PlS Planned sale
1,681 -3.0%
35.54
US$59,743 		1,681 -3.0% 35.54 US$59,743
2025-03-04 2025-03-03
PlS Planned sale
1,187 -2.3%
35.54
US$42,186 		1,187 -2.3% 35.54 US$42,186
2025-03-04 2025-03-03
PlS Planned sale
1,137 -2.4%
35.54
US$40,409 		1,137 -2.4% 35.54 US$40,409
2025-03-03 2025-03-03
PrS Proposed sale
4,005
35.54
US$142,338 		4,005 35.54 US$142,338
2024-07-03 2024-07-01
PlS Planned sale
3,705 -7.8%
43.85
US$162,464 		3,705 -7.8% 43.85 US$162,464
2024-07-01 2024-07-01
PrS Proposed sale
3,705
43.85
US$162,464 		3,705 43.85 US$162,464
2024-03-05 2024-03-05
PlS Planned sale
1,349 -3.3%
32.57
US$43,937 		1,349 -3.3% 32.57 US$43,937
2024-03-05 2024-03-05
PlS Planned sale
1,293 -3.4%
32.57
US$42,113 		1,293 -3.4% 32.57 US$42,113
2024-03-01 2024-03-01
PrS Proposed sale
2,642
32.23
US$85,152 		2,642 32.23 US$85,152
2024-02-14 2024-02-14
PlS Planned sale
642 -1.9%
25.14
US$16,140 		642 -1.9% 25.14 US$16,140
2024-01-24 2024-01-24
PlS Planned sale
1,708 -5.1%
21.64
US$36,961 		1,708 -5.1% 21.64 US$36,961
2024-01-09 2024-01-09
PlS Planned sale
1,789 -6.0%
22.99
US$41,129 		1,789 -6.0% 22.99 US$41,129